These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 37004461

  • 1. Integrating cognitive bias modification for pain and opioid cues into medication for opioid use disorder clinical care: Feasibility, acceptability, and preliminary results.
    MacLean RR, Heapy AA, Waters AJ, Wolkowicz N, Szollosy SK, Meyerovich J, Sofuoglu M.
    Drug Alcohol Depend; 2023 May 01; 246():109857. PubMed ID: 37004461
    [Abstract] [Full Text] [Related]

  • 2. Feasibility of Web-Based Single-Session Empowered Relief in Patients With Chronic Pain Taking Methadone or Buprenorphine: Protocol for a Single-Arm Trial.
    Klein MR, Darnall BD, You DS.
    JMIR Res Protoc; 2024 Jun 06; 13():e53784. PubMed ID: 38843513
    [Abstract] [Full Text] [Related]

  • 3. Virtual reality-based Mindfulness-Oriented Recovery Enhancement (MORE-VR) as an adjunct to medications for opioid use disorder: a Phase 1 trial.
    Garland EL, Recasens M, Taple BJ, Donaldson GW, Weisberg RB.
    Ann Med; 2024 Dec 06; 56(1):2392870. PubMed ID: 39172534
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. An evaluation of the feasibility, acceptability, and preliminary efficacy of cognitive-behavioral therapy for opioid use disorder and chronic pain.
    Barry DT, Beitel M, Cutter CJ, Fiellin DA, Kerns RD, Moore BA, Oberleitner L, Madden LM, Liong C, Ginn J, Schottenfeld RS.
    Drug Alcohol Depend; 2019 Jan 01; 194():460-467. PubMed ID: 30508769
    [Abstract] [Full Text] [Related]

  • 6. A preliminary investigation of the acute effects of delta-9-tetrahydrocannabinol on pain and opioid attentional bias among persons with opioid use disorder.
    Wolkowicz NR, Sofuoglu M, Pittman B, Meyerovich J, MacLean RR, De Aquino JP.
    J Psychiatr Res; 2024 Sep 01; 177():90-95. PubMed ID: 38991269
    [Abstract] [Full Text] [Related]

  • 7. Mental Health Distress Is Associated With Higher Pain Interference in Patients With Opioid Use Disorder Stabilized on Buprenorphine or Methadone.
    Leyde S, Price CJ, Colgan DD, Pike KC, Tsui JI, Merrill JO.
    Subst Use Addctn J; 2024 Jul 01; 45(3):423-433. PubMed ID: 38327009
    [Abstract] [Full Text] [Related]

  • 8. Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs.
    Hughto JMW, Tapper A, Rapisarda SS, Stopka TJ, Palacios WR, Case P, Silcox J, Moyo P, Green TC.
    Subst Abuse Treat Prev Policy; 2023 May 22; 18(1):30. PubMed ID: 37217975
    [Abstract] [Full Text] [Related]

  • 9. Availability of Medications for the Treatment of Opioid Use Disorder Among Pregnant and Postpartum Individuals in US Jails.
    Sufrin C, Kramer CT, Terplan M, Fiscella K, Olson S, Voegtline K, Latkin C.
    JAMA Netw Open; 2022 Jan 04; 5(1):e2144369. PubMed ID: 35050354
    [Abstract] [Full Text] [Related]

  • 10. Psycho-physiological response to pain among individuals with comorbid pain and opioid use disorder: Implications for patients with prolonged abstinence.
    Wachholtz A, Gonzalez G, Ziedonis D.
    Am J Drug Alcohol Abuse; 2019 Jan 04; 45(5):495-505. PubMed ID: 31246117
    [Abstract] [Full Text] [Related]

  • 11. Attentional bias for prescription opioid cues among opioid dependent chronic pain patients.
    Garland EL, Froeliger BE, Passik SD, Howard MO.
    J Behav Med; 2013 Dec 04; 36(6):611-20. PubMed ID: 22968666
    [Abstract] [Full Text] [Related]

  • 12. OUD MEETS: A novel program to increase initiation of medications for opioid use disorder and improve outcomes for hospitalized patients being discharged to skilled nursing facilities.
    Tassey TE, Ott GE, Alvanzo AAH, Peirce JM, Antoine D, Buresh ME.
    J Subst Abuse Treat; 2022 Dec 04; 143():108895. PubMed ID: 36215913
    [Abstract] [Full Text] [Related]

  • 13. Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder.
    Thakrar AP, Uritsky TJ, Christopher C, Winston A, Ronning K, Sigueza AL, Caputo A, McFadden R, Olenik JM, Perrone J, Delgado MK, Lowenstein M, Compton P.
    Addict Sci Clin Pract; 2023 Feb 24; 18(1):13. PubMed ID: 36829242
    [Abstract] [Full Text] [Related]

  • 14. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
    Velasquez M, Flannery M, Badolato R, Vittitow A, McDonald RD, Tofighi B, Garment AR, Giftos J, Lee JD.
    Addict Sci Clin Pract; 2019 Oct 01; 14(1):37. PubMed ID: 31570100
    [Abstract] [Full Text] [Related]

  • 15. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
    Sufrin C, Sutherland L, Beal L, Terplan M, Latkin C, Clarke JG.
    Addiction; 2020 Nov 01; 115(11):2057-2065. PubMed ID: 32141128
    [Abstract] [Full Text] [Related]

  • 16. "You have to take this medication, but then you get punished for taking it:" lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period.
    Schiff DM, Work EC, Muftu S, Partridge S, MacMillan KDL, Gray JR, Hoeppner BB, Kelly JF, Greenfield SF, Jones HE, Wilens TE, Terplan M, Bernstein J.
    J Subst Abuse Treat; 2022 Aug 01; 139():108765. PubMed ID: 35341614
    [Abstract] [Full Text] [Related]

  • 17. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.
    Gordon AJ, Drexler K, Hawkins EJ, Burden J, Codell NK, Mhatre-Owens A, Dungan MT, Hagedorn H.
    Subst Abus; 2020 Aug 01; 41(3):275-282. PubMed ID: 32697170
    [Abstract] [Full Text] [Related]

  • 18. A pilot study assessing acceptability and feasibility of hatha yoga for chronic pain in people receiving opioid agonist therapy for opioid use disorder.
    Uebelacker LA, Van Noppen D, Tremont G, Bailey G, Abrantes A, Stein M.
    J Subst Abuse Treat; 2019 Oct 01; 105():19-27. PubMed ID: 31443887
    [Abstract] [Full Text] [Related]

  • 19. Attentional Bias for Opioids in Taiwanese Heavy Smokers with Chronic Noncancer Pain.
    Liu LJ, Lin EM, Tsao SL, Wang HY, Ho MC.
    Medicina (Kaunas); 2024 Jul 08; 60(7):. PubMed ID: 39064536
    [Abstract] [Full Text] [Related]

  • 20. Familial perceptions of appropriate treatment types and goals for a family member who has opioid use disorder.
    Nayak SM, Huhn AS, Bergeria CL, Strain EC, Dunn KE.
    Drug Alcohol Depend; 2021 Apr 01; 221():108649. PubMed ID: 33640679
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.